<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>Aaj TV English News - News</title>
    <link>https://english.aaj.tv/</link>
    <description>Aaj TV English</description>
    <language>en-Us</language>
    <copyright>Copyright 2026</copyright>
    <pubDate>Sun, 05 Apr 2026 21:50:46 +0500</pubDate>
    <lastBuildDate>Sun, 05 Apr 2026 21:50:46 +0500</lastBuildDate>
    <ttl>60</ttl>
    <item xmlns:default="http://purl.org/rss/1.0/modules/content/">
      <title>World stock markets rise as Covid fears ease
</title>
      <link>https://english.aaj.tv/news/30274361/</link>
      <description>&lt;p&gt;&lt;strong&gt;LONDON: Asian and European stock markets advanced Thursday on fading fears over both the Omicron coronavirus variant and elevated inflationary pressures, dealers said.&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;Natural gas prices continued to fall sharply from record peaks that were struck earlier this week, but crude oil edged upwards.&lt;/p&gt;

&lt;p&gt;The upbeat pre-holiday markets mood was helped by two preliminary studies from Britain indicating Omicron infections were less likely to result in hospitalisation compared with the Delta variant, confirming a trend first identified in South Africa.&lt;/p&gt;

&lt;p&gt;Global equities climbed on "optimism that Omicron could lead to fewer hospitalisations than Delta", noted Interactive Investor analyst Victoria Scholar.&lt;/p&gt;

&lt;p&gt;The cautious optimism was also lifted by news that the US Food and Drug Administration had authorised Pfizer's anti-Covid pill, providing fresh tools to battle the disease.&lt;/p&gt;

&lt;p&gt;Sentiment won another shot in the arm after Britain's AstraZeneca revealed that the third, or booster, dose of its Covid-19 vaccine "significantly" lifted antibody levels against the Omicron strain in a laboratory study.&lt;/p&gt;

&lt;p&gt;New cases of the highly mutated Omicron strain however continued to soar, but market watchers are becoming more confident the health effects will be milder than with earlier strains.&lt;/p&gt;

&lt;p&gt;Wall Street closed with healthy gains on Wednesday after US data showed consumers remained upbeat about the economy despite the rise of the fast-spreading Omicron strain.&lt;/p&gt;

&lt;p&gt;The Conference Board's consumer confidence index jumped nearly four points to 115.8 compared to the prior month.&lt;/p&gt;

&lt;p&gt;Sentiment was also boosted by revised data from the US Commerce Department showing GDP expanded at a faster annual rate of 2.3 percent in the third quarter, up from earlier estimates of 2.1 percent.&lt;/p&gt;

&lt;p&gt;The positive mood spilled over into Asia Thursday, with Tokyo adding 0.8 percent.&lt;/p&gt;

&lt;p&gt;Even a Covid lockdown in the Chinese city of Xi'an failed to dampen enthusiasm, with Shanghai closing 0.6 percent higher and Hong Kong up 0.4 percent.&lt;/p&gt;
</description>
      <content:encoded xmlns="http://purl.org/rss/1.0/modules/content/"><![CDATA[<p><strong>LONDON: Asian and European stock markets advanced Thursday on fading fears over both the Omicron coronavirus variant and elevated inflationary pressures, dealers said.</strong></p>

<p>Natural gas prices continued to fall sharply from record peaks that were struck earlier this week, but crude oil edged upwards.</p>

<p>The upbeat pre-holiday markets mood was helped by two preliminary studies from Britain indicating Omicron infections were less likely to result in hospitalisation compared with the Delta variant, confirming a trend first identified in South Africa.</p>

<p>Global equities climbed on "optimism that Omicron could lead to fewer hospitalisations than Delta", noted Interactive Investor analyst Victoria Scholar.</p>

<p>The cautious optimism was also lifted by news that the US Food and Drug Administration had authorised Pfizer's anti-Covid pill, providing fresh tools to battle the disease.</p>

<p>Sentiment won another shot in the arm after Britain's AstraZeneca revealed that the third, or booster, dose of its Covid-19 vaccine "significantly" lifted antibody levels against the Omicron strain in a laboratory study.</p>

<p>New cases of the highly mutated Omicron strain however continued to soar, but market watchers are becoming more confident the health effects will be milder than with earlier strains.</p>

<p>Wall Street closed with healthy gains on Wednesday after US data showed consumers remained upbeat about the economy despite the rise of the fast-spreading Omicron strain.</p>

<p>The Conference Board's consumer confidence index jumped nearly four points to 115.8 compared to the prior month.</p>

<p>Sentiment was also boosted by revised data from the US Commerce Department showing GDP expanded at a faster annual rate of 2.3 percent in the third quarter, up from earlier estimates of 2.1 percent.</p>

<p>The positive mood spilled over into Asia Thursday, with Tokyo adding 0.8 percent.</p>

<p>Even a Covid lockdown in the Chinese city of Xi'an failed to dampen enthusiasm, with Shanghai closing 0.6 percent higher and Hong Kong up 0.4 percent.</p>
]]></content:encoded>
      <category/>
      <guid>https://english.aaj.tv/news/30274361</guid>
      <pubDate>Thu, 23 Dec 2021 19:02:53 +0500</pubDate>
      <author>none@none.com (AFP)</author>
      <media:content url="https://i.aaj.tv/large/2021/12/61c481317065c.jpg" type="image/jpeg" medium="image" height="768" width="1024">
        <media:thumbnail url="https://i.aaj.tv/thumbnail/2021/12/61c481317065c.jpg"/>
        <media:title>Global equities climbed on "optimism that Omicron could lead to fewer hospitalisations than Delta".
</media:title>
      </media:content>
    </item>
  </channel>
</rss>
